전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,045 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

ADCLimited DatastaleQuantumLeap Healthcare Collabor…Phase 2

[vic-]trastuzumab duocarmazine (SYD985, SYD985 ([vic-]trastuzumab duocarmazine))

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#antibody-drug-conjugate#BreastNeoplasms+2
Trials 7Status Recruiting
AntibodyLimited DatastaleRochePhase 1

trastuzumab vc-seco-DUBA (SYD985, SYD985 (trastuzumab vc-seco-DUBA))

Solid Tumors · Solid Tumors

#SolidTumors#Antibody#Phase1#monoclonal-antibody#Roche
Trials 7Status Active
AntibodyLimited DatastaleARCAGYPhase 2

Ubamatamab (Ubamatamab)

Ovarian Cancer · Recurrent Ovarian Cancer

#RecurrentOvarianCancer#Antibody#Phase2#monoclonal-antibody#OvarianCancer+1
Trials 7Status Recruiting
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 2

anti-MUC1 CAR-T cells (anti-MUC1 CAR-T cells)

Advanced Esophageal Cancer · Malignant Glioma of Brain

#MalignantGliomaofBrain#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 7Status Active
CGTAAVLimited DatastaleBrain Neurotherapy Bio, Inc.Phase 1

AAV2-GDNF (AAV2-GDNF)

Parkinson's Disease · Parkinson's Disease

#ParkinsonsDisease#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 6Status Recruiting
CGTAAVLimited DatastaleBrain Neurotherapy Bio, Inc.Phase 1

AAV2-GDNF gene therapy (AAV2-GDNF gene therapy)

Multiple System Atrophy · Multiple System Atrophy

#MultipleSystemAtrophy#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 6Status Recruiting
CGTLimited DatastaleStephan Grupp MD PhDPhase 2

CART22-65s (Autologous, humanized anti-CD22 CAR T cell therapy, Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s))

B-cell Acute Lymphoblastic Leukemia; B Lineage Lymphoblastic Lymphoma · CD22

#CD22#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 6Status Recruiting
ADCLimited DatastaleGSKPhase 2

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin lyophilized powder)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#antibody-drug-conjugate#GSK
Trials 6Status Active
CGTLimited DatastaleShanghai AbelZeta Ltd.Phase 1

C-CAR-011 (C-CAR-011)

Refractory Diffuse Large B-Cell Lymphoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 6Status Active
CGTLimited DatastaleShanghai AbelZeta Ltd.Phase 1

C-CAR011 (C-CAR011)

Refractory or Relapsed Non-Hodgkin Lymphoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 6Status Active
CGTLimited DatastaleShanghai AbelZeta Ltd.Phase 1

C-CAR088 (C-CAR088)

Relapsed or Refractory Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 6Status Active
CGTLimited DatastaleCabaletta BioPhase 2

CABA-201 (CABA-201)

Relapsing Multiple Sclerosis (RMS); Progressive Multiple Sclerosis (PMS) · Pemphigus Vulgaris

#PemphigusVulgaris#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 6Status Recruiting
AntibodyLimited DatastaleMerckPhase 2

pembrolizumab (Keytruda, Coformulated favezelimab/pembrolizumab)

Metastatic Urothelial Carcinoma; Urothelial Neoplasms · Metastatic Urothelial Carcinoma

#MetastaticUrothelialCarcinoma#Antibody#Phase2#monoclonal-antibody#UrothelialNeoplasms+1
Trials 6Status Recruiting
ADCLimited DatastaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin Plus Cadonilimab)

Bile Duct Adenocarcinoma Non-Resectable; HER2 Gene Mutation · HER2

#HER2#ADC#Phase2#antibody-drug-conjugate#BileDuctAdenocarcinomaNon-Resect+2
Trials 6Status Active
ADCLimited DatastaleRemeGenApproved

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin and Gemcitabine)

Radical Cystectomy; Urothelial Carcinoma · Radical Cystectomy

#RadicalCystectomy#ADC#Approved#antibody-drug-conjugate#UrothelialCarcinoma+1
Trials 6Status Active
AntibodyLimited DatastaleKite, A Gilead CompanyPhase 1

Lenzilumab (Lenzilumab)

Relapsed/Refractory Large B-cell Lymphoma · FRα

#FR#Antibody#Phase1#monoclonal-antibody#Relapsed+2
Trials 6Status Discontinued
ADCLimited DatastaleAbbViePhase 3

Mirvetuximab soravtansine plus Bevacizumab (Mirvetuximab soravtansine plus Bevacizumab)

Ovarian Cancer; Peritoneal Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase3#antibody-drug-conjugate#PeritonealCancer+1
Trials 6Status Recruiting
ADCLimited DatastaleMing-Yuan ChenPhase 3

Neoadjuvant and Adjuvant Becotatug Vedotin (Neoadjuvant and Adjuvant Becotatug Vedotin)

Locally Advanced Head and Neck Squamous Cell Carcinoma · Locally Advanced Head and Neck Squamous

#LocallyAdvancedHeadandNeckSquamo#ADC#Phase3#antibody-drug-conjugate#Ming-Yuan
Trials 6Status Recruiting
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Phase 2

T cell injection targeting CD7 chimeric antigen receptor (T cell injection targeting CD7 chimeric antigen receptor)

CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 6Status Recruiting
CGTLimited DatastaleTILT Biotherapeutics Ltd.Phase 2

TILT-123 (TILT-123)

Melanoma; Head and Neck Squamous Cell Carcinoma · Melanoma

#Melanoma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 6Status Recruiting

24 / 103 pages

← PreviousNext →